Ciliatech obtains CE certification for the Intercil Uveal Spacer surgical implant; Zeiss receives CE mark for a new device that uses AI to automate OCT assessment; and the FDA extends the target action dates for two Eylea HD submissions.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Leaders from the Tear Film and Ocular Surface Society discuss the biggest takeaways from the recently released TFOS DEWS III report.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Charles Wykoff, MD, PhD, shares his experience performing the first commercial case for a patient with MacTel; VSY Biotechnology launches its Enova Hydrophobic IOLs with a new preloaded delivery system; and an app is launched that syncs AI directly to leading OCT devices.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium.  

Learn more about your ad choices. Visit megaphone.fm/adchoices

Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease.

Learn more about your ad choices. Visit megaphone.fm/adchoices